Global Stem Cell Manufacturing Market to Reach $16.5 Billion by 2027
Abstract: - Global Stem Cell Manufacturing Market to Reach $16. 5 Billion by 2027. - Amid the COVID-19 crisis, the global market for Stem Cell Manufacturing estimated at US$11.
New York, May 18, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Stem Cell Manufacturing Industry" - https://www.reportlinker.com/p06033004/?utm_source=GNW
9 Billion in the year 2020, is projected to reach a revised size of US$16.5 Billion by 2027, growing at a CAGR of 4.9% over the analysis period 2020-2027. Culture Media, one of the segments analyzed in the report, is projected to record a 4.7% CAGR and reach US$6.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Consumables segment is readjusted to a revised 5.2% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $3.5 Billion, While China is Forecast to Grow at 4.6% CAGR
- The Stem Cell Manufacturing market in the U.S. is estimated at US$3.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2027 trailing a CAGR of 4.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 3.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.
- Instruments Segment to Record 4.3% CAGR
- In the global Instruments segment, USA, Canada, Japan, China and Europe will drive the 4.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.8 Billion in the year 2020 will reach a projected size of US$2.4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.9 Billion by the year 2027.
- Select Competitors (Total 33 Featured) -
Anterogen
Becton, Dickinson and Company
Bio-Rad Laboratories
Cellular Dynamics International
Holostem Terapie Avanzate
Lonza Group
Medipost
Merck Group
Miltenyi Biotec
Osiris Therapeutics
Pharmicell
Pluristem Therapeutics
Stemcell Technologies
Takara Bio Group
Thermo Fisher Scientific
Read the full report: https://www.reportlinker.com/p06033004/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Stem Cell
Manufacturing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR
Table 2: World Historic Review for Stem Cell Manufacturing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 3: World 15-Year Perspective for Stem Cell Manufacturing
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2012, 2020 & 2027
Table 4: World Current & Future Analysis for Culture Media by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR
Table 5: World Historic Review for Culture Media by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR
Table 6: World 15-Year Perspective for Culture Media by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 7: World Current & Future Analysis for Consumables by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR
Table 8: World Historic Review for Consumables by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR
Table 9: World 15-Year Perspective for Consumables by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 10: World Current & Future Analysis for Instruments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR
Table 11: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR
Table 12: World 15-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 13: World Current & Future Analysis for Stem Cell Lines
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR
Table 14: World Historic Review for Stem Cell Lines by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 15: World 15-Year Perspective for Stem Cell Lines by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 16: World Current & Future Analysis for Research-based by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR
Table 17: World Historic Review for Research-based by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 18: World 15-Year Perspective for Research-based by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 19: World Current & Future Analysis for Cell & Tissue
Banking by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR
Table 20: World Historic Review for Cell & Tissue Banking by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 21: World 15-Year Perspective for Cell & Tissue Banking
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
Table 22: World Current & Future Analysis for Clinical-based by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR
Table 23: World Historic Review for Clinical-based by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 24: World 15-Year Perspective for Clinical-based by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
UNITED STATES
Table 25: USA Current & Future Analysis for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR
Table 26: USA Historic Review for Stem Cell Manufacturing by
Product - Culture Media, Consumables, Instruments and Stem Cell
Lines Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 27: USA 15-Year Perspective for Stem Cell Manufacturing
by Product - Percentage Breakdown of Value Sales for Culture
Media, Consumables, Instruments and Stem Cell Lines for the
Years 2012, 2020 & 2027
Table 28: USA Current & Future Analysis for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 29: USA Historic Review for Stem Cell Manufacturing by
Application - Research-based, Cell & Tissue Banking and
Clinical-based Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR
Table 30: USA 15-Year Perspective for Stem Cell Manufacturing
by Application - Percentage Breakdown of Value Sales for
Research-based, Cell & Tissue Banking and Clinical-based for
the Years 2012, 2020 & 2027
CANADA
Table 31: Canada Current & Future Analysis for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR
Table 32: Canada Historic Review for Stem Cell Manufacturing by
Product - Culture Media, Consumables, Instruments and Stem Cell
Lines Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 33: Canada 15-Year Perspective for Stem Cell
Manufacturing by Product - Percentage Breakdown of Value Sales
for Culture Media, Consumables, Instruments and Stem Cell Lines
for the Years 2012, 2020 & 2027
Table 34: Canada Current & Future Analysis for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 35: Canada Historic Review for Stem Cell Manufacturing by
Application - Research-based, Cell & Tissue Banking and
Clinical-based Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR
Table 36: Canada 15-Year Perspective for Stem Cell
Manufacturing by Application - Percentage Breakdown of Value
Sales for Research-based, Cell & Tissue Banking and
Clinical-based for the Years 2012, 2020 & 2027
JAPAN
Table 37: Japan Current & Future Analysis for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR
Table 38: Japan Historic Review for Stem Cell Manufacturing by
Product - Culture Media, Consumables, Instruments and Stem Cell
Lines Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 39: Japan 15-Year Perspective for Stem Cell Manufacturing
by Product - Percentage Breakdown of Value Sales for Culture
Media, Consumables, Instruments and Stem Cell Lines for the
Years 2012, 2020 & 2027
Table 40: Japan Current & Future Analysis for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 41: Japan Historic Review for Stem Cell Manufacturing by
Application - Research-based, Cell & Tissue Banking and
Clinical-based Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR
Table 42: Japan 15-Year Perspective for Stem Cell Manufacturing
by Application - Percentage Breakdown of Value Sales for
Research-based, Cell & Tissue Banking and Clinical-based for
the Years 2012, 2020 & 2027
CHINA
Table 43: China Current & Future Analysis for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR
Table 44: China Historic Review for Stem Cell Manufacturing by
Product - Culture Media, Consumables, Instruments and Stem Cell
Lines Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 45: China 15-Year Perspective for Stem Cell Manufacturing
by Product - Percentage Breakdown of Value Sales for Culture
Media, Consumables, Instruments and Stem Cell Lines for the
Years 2012, 2020 & 2027
Table 46: China Current & Future Analysis for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 47: China Historic Review for Stem Cell Manufacturing by
Application - Research-based, Cell & Tissue Banking and
Clinical-based Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR
Table 48: China 15-Year Perspective for Stem Cell Manufacturing
by Application - Percentage Breakdown of Value Sales for
Research-based, Cell & Tissue Banking and Clinical-based for
the Years 2012, 2020 & 2027
EUROPE
Table 49: Europe Current & Future Analysis for Stem Cell
Manufacturing by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027 and % CAGR
Table 50: Europe Historic Review for Stem Cell Manufacturing by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 51: Europe 15-Year Perspective for Stem Cell
Manufacturing by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK and Rest of Europe
Markets for Years 2012, 2020 & 2027
Table 52: Europe Current & Future Analysis for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR
Table 53: Europe Historic Review for Stem Cell Manufacturing by
Product - Culture Media, Consumables, Instruments and Stem Cell
Lines Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 54: Europe 15-Year Perspective for Stem Cell
Manufacturing by Product - Percentage Breakdown of Value Sales
for Culture Media, Consumables, Instruments and Stem Cell Lines
for the Years 2012, 2020 & 2027
Table 55: Europe Current & Future Analysis for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 56: Europe Historic Review for Stem Cell Manufacturing by
Application - Research-based, Cell & Tissue Banking and
Clinical-based Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR
Table 57: Europe 15-Year Perspective for Stem Cell
Manufacturing by Application - Percentage Breakdown of Value
Sales for Research-based, Cell & Tissue Banking and
Clinical-based for the Years 2012, 2020 & 2027
FRANCE
Table 58: France Current & Future Analysis for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR
Table 59: France Historic Review for Stem Cell Manufacturing by
Product - Culture Media, Consumables, Instruments and Stem Cell
Lines Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 60: France 15-Year Perspective for Stem Cell
Manufacturing by Product - Percentage Breakdown of Value Sales
for Culture Media, Consumables, Instruments and Stem Cell Lines
for the Years 2012, 2020 & 2027
Table 61: France Current & Future Analysis for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 62: France Historic Review for Stem Cell Manufacturing by
Application - Research-based, Cell & Tissue Banking and
Clinical-based Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR
Table 63: France 15-Year Perspective for Stem Cell
Manufacturing by Application - Percentage Breakdown of Value
Sales for Research-based, Cell & Tissue Banking and
Clinical-based for the Years 2012, 2020 & 2027
GERMANY
Table 64: Germany Current & Future Analysis for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR
Table 65: Germany Historic Review for Stem Cell Manufacturing
by Product - Culture Media, Consumables, Instruments and Stem
Cell Lines Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR
Table 66: Germany 15-Year Perspective for Stem Cell
Manufacturing by Product - Percentage Breakdown of Value Sales
for Culture Media, Consumables, Instruments and Stem Cell Lines
for the Years 2012, 2020 & 2027
Table 67: Germany Current & Future Analysis for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 68: Germany Historic Review for Stem Cell Manufacturing
by Application - Research-based, Cell & Tissue Banking and
Clinical-based Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR
Table 69: Germany 15-Year Perspective for Stem Cell
Manufacturing by Application - Percentage Breakdown of Value
Sales for Research-based, Cell & Tissue Banking and
Clinical-based for the Years 2012, 2020 & 2027
ITALY
Table 70: Italy Current & Future Analysis for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR
Table 71: Italy Historic Review for Stem Cell Manufacturing by
Product - Culture Media, Consumables, Instruments and Stem Cell
Lines Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 72: Italy 15-Year Perspective for Stem Cell Manufacturing
by Product - Percentage Breakdown of Value Sales for Culture
Media, Consumables, Instruments and Stem Cell Lines for the
Years 2012, 2020 & 2027
Table 73: Italy Current & Future Analysis for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 74: Italy Historic Review for Stem Cell Manufacturing by
Application - Research-based, Cell & Tissue Banking and
Clinical-based Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR
Table 75: Italy 15-Year Perspective for Stem Cell Manufacturing
by Application - Percentage Breakdown of Value Sales for
Research-based, Cell & Tissue Banking and Clinical-based for
the Years 2012, 2020 & 2027
UNITED KINGDOM
Table 76: UK Current & Future Analysis for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR
Table 77: UK Historic Review for Stem Cell Manufacturing by
Product - Culture Media, Consumables, Instruments and Stem Cell
Lines Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR
Table 78: UK 15-Year Perspective for Stem Cell Manufacturing by
Product - Percentage Breakdown of Value Sales for Culture
Media, Consumables, Instruments and Stem Cell Lines for the
Years 2012, 2020 & 2027
Table 79: UK Current & Future Analysis for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 80: UK Historic Review for Stem Cell Manufacturing by
Application - Research-based, Cell & Tissue Banking and
Clinical-based Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR
Table 81: UK 15-Year Perspective for Stem Cell Manufacturing by
Application - Percentage Breakdown of Value Sales for
Research-based, Cell & Tissue Banking and Clinical-based for
the Years 2012, 2020 & 2027
REST OF EUROPE
Table 82: Rest of Europe Current & Future Analysis for Stem
Cell Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR
Table 83: Rest of Europe Historic Review for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 84: Rest of Europe 15-Year Perspective for Stem Cell
Manufacturing by Product - Percentage Breakdown of Value Sales
for Culture Media, Consumables, Instruments and Stem Cell Lines
for the Years 2012, 2020 & 2027
Table 85: Rest of Europe Current & Future Analysis for Stem
Cell Manufacturing by Application - Research-based, Cell &
Tissue Banking and Clinical-based - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR
Table 86: Rest of Europe Historic Review for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR
Table 87: Rest of Europe 15-Year Perspective for Stem Cell
Manufacturing by Application - Percentage Breakdown of Value
Sales for Research-based, Cell & Tissue Banking and
Clinical-based for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Table 88: Asia-Pacific Current & Future Analysis for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR
Table 89: Asia-Pacific Historic Review for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 90: Asia-Pacific 15-Year Perspective for Stem Cell
Manufacturing by Product - Percentage Breakdown of Value Sales
for Culture Media, Consumables, Instruments and Stem Cell Lines
for the Years 2012, 2020 & 2027
Table 91: Asia-Pacific Current & Future Analysis for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 92: Asia-Pacific Historic Review for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR
Table 93: Asia-Pacific 15-Year Perspective for Stem Cell
Manufacturing by Application - Percentage Breakdown of Value
Sales for Research-based, Cell & Tissue Banking and
Clinical-based for the Years 2012, 2020 & 2027
REST OF WORLD
Table 94: Rest of World Current & Future Analysis for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR
Table 95: Rest of World Historic Review for Stem Cell
Manufacturing by Product - Culture Media, Consumables,
Instruments and Stem Cell Lines Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR
Table 96: Rest of World 15-Year Perspective for Stem Cell
Manufacturing by Product - Percentage Breakdown of Value Sales
for Culture Media, Consumables, Instruments and Stem Cell Lines
for the Years 2012, 2020 & 2027
Table 97: Rest of World Current & Future Analysis for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Table 98: Rest of World Historic Review for Stem Cell
Manufacturing by Application - Research-based, Cell & Tissue
Banking and Clinical-based Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR
Table 99: Rest of World 15-Year Perspective for Stem Cell
Manufacturing by Application - Percentage Breakdown of Value
Sales for Research-based, Cell & Tissue Banking and
Clinical-based for the Years 2012, 2020 & 2027
IV. COMPETITION
Total Companies Profiled: 33
Read the full report: https://www.reportlinker.com/p06033004/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001